09 February 2017: Sysmex Enters into Research Collaboration Agreement in Relation to Cancer and Rare Diseases with the University of Tokyo

Sysmex Corporation and the University of Tokyo have entered into a research collaboration agreement involving the development of a target gene panel. The objective is to analyze lung cancer, sarcoma and other specified types of diseases, and analyze genetic mutations related to rare diseases with a view to the clinical application of genomic medicine.